Consumer Electronics
Compare Stocks
2 / 10Stock Comparison
BWNB vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
BWNB vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Consumer Electronics | Industrial - Machinery |
| Market Cap | $2.38B | $79.02B |
| Revenue (TTM) | $635M | $18.32B |
| Net Income (TTM) | $-36M | $2.44B |
| Gross Margin | 25.5% | 52.7% |
| Operating Margin | 5.2% | 19.8% |
| Forward P/E | — | 21.7x |
| Total Debt | $369M | $13.76B |
| Cash & Equiv. | $90M | $1.54B |
BWNB vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 21 | May 26 | Return |
|---|---|---|---|
| Babcock & Wilcox En… (BWNB) | 100 | 100.8 | +0.8% |
| Emerson Electric Co. (EMR) | 100 | 151.8 | +51.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BWNB vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BWNB is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.16, current ratio 1.22x
- Beta 1.16, yield 0.6%, current ratio 1.22x
- Beta 1.16 vs EMR's 1.52
EMR carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 37 yrs, beta 1.52, yield 1.5%
- Rev growth 3.0%, EPS growth 17.8%, 3Y rev CAGR 9.3%
- 206.6% 10Y total return vs BWNB's 29.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.0% revenue growth vs BWNB's -18.1% | |
| Quality / Margins | 13.3% margin vs BWNB's -5.7% | |
| Stability / Safety | Beta 1.16 vs EMR's 1.52 | |
| Dividends | 1.5% yield, 37-year raise streak, vs BWNB's 0.6% | |
| Momentum (1Y) | +171.7% vs EMR's +30.4% | |
| Efficiency (ROA) | 5.8% ROA vs BWNB's -5.3%, ROIC 8.2% vs 9.1% |
BWNB vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BWNB vs EMR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMR is the larger business by revenue, generating $18.3B annually — 28.8x BWNB's $635M. EMR is the more profitable business, keeping 13.3% of every revenue dollar as net income compared to BWNB's -5.7%. On growth, BWNB holds the edge at +142.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $635M | $18.3B |
| EBITDAEarnings before interest/tax | $43M | $4.7B |
| Net IncomeAfter-tax profit | -$36M | $2.4B |
| Free Cash FlowCash after capex | -$86M | $3.1B |
| Gross MarginGross profit ÷ Revenue | +25.5% | +52.7% |
| Operating MarginEBIT ÷ Revenue | +5.2% | +19.8% |
| Net MarginNet income ÷ Revenue | -5.7% | +13.3% |
| FCF MarginFCF ÷ Revenue | -13.5% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +142.9% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +106.4% | +28.2% |
Valuation Metrics
BWNB leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
On an enterprise value basis, EMR's 18.1x EV/EBITDA is more attractive than BWNB's 80.5x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.4B | $79.0B |
| Enterprise ValueMkt cap + debt − cash | $2.7B | $91.2B |
| Trailing P/EPrice ÷ TTM EPS | -52.08x | 34.92x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 21.71x |
| PEG RatioP/E ÷ EPS growth rate | — | 7.73x |
| EV / EBITDAEnterprise value multiple | 80.53x | 18.07x |
| Price / SalesMarket cap ÷ Revenue | 4.05x | 4.39x |
| Price / BookPrice ÷ Book value/share | — | 3.94x |
| Price / FCFMarket cap ÷ FCF | — | 29.63x |
Profitability & Efficiency
EMR leads this category, winning 4 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs BWNB's 2/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | +12.1% |
| ROA (TTM)Return on assets | -5.3% | +5.8% |
| ROICReturn on invested capital | +9.1% | +8.2% |
| ROCEReturn on capital employed | +7.5% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 7 |
| Debt / EquityFinancial leverage | — | 0.68x |
| Net DebtTotal debt minus cash | $279M | $12.2B |
| Cash & Equiv.Liquid assets | $90M | $1.5B |
| Total DebtShort + long-term debt | $369M | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 0.97x | 6.46x |
Total Returns (Dividends Reinvested)
EMR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EMR five years ago would be worth $15,945 today (with dividends reinvested), compared to $12,924 for BWNB. Over the past 12 months, BWNB leads with a +171.7% total return vs EMR's +30.4%. The 3-year compound annual growth rate (CAGR) favors EMR at 20.7% vs BWNB's 13.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +4.0% | +4.3% |
| 1-Year ReturnPast 12 months | +171.7% | +30.4% |
| 3-Year ReturnCumulative with dividends | +45.0% | +75.9% |
| 5-Year ReturnCumulative with dividends | +29.2% | +59.5% |
| 10-Year ReturnCumulative with dividends | +29.2% | +206.6% |
| CAGR (3Y)Annualised 3-year return | +13.2% | +20.7% |
Risk & Volatility
BWNB leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BWNB is the less volatile stock with a 1.16 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BWNB currently trades 98.4% from its 52-week high vs EMR's 85.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.16x | 1.52x |
| 52-Week HighHighest price in past year | $25.40 | $165.15 |
| 52-Week LowLowest price in past year | $6.15 | $108.37 |
| % of 52W HighCurrent price vs 52-week peak | +98.4% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 71.3 | 61.3 |
| Avg Volume (50D)Average daily shares traded | 10K | 2.8M |
Analyst Outlook
EMR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
For income investors, EMR offers the higher dividend yield at 1.49% vs BWNB's 0.57%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $161.92 |
| # AnalystsCovering analysts | — | 41 |
| Dividend YieldAnnual dividend ÷ price | +0.6% | +1.5% |
| Dividend StreakConsecutive years of raises | 0 | 37 |
| Dividend / ShareAnnual DPS | $0.14 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | +1.6% |
EMR leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BWNB leads in 2 (Valuation Metrics, Risk & Volatility).
BWNB vs EMR: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is BWNB or EMR a better buy right now?
For growth investors, Emerson Electric Co.
(EMR) is the stronger pick with 3. 0% revenue growth year-over-year, versus -18. 1% for Babcock & Wilcox Enterprises, I (BWNB). Emerson Electric Co. (EMR) offers the better valuation at 34. 9x trailing P/E (21. 7x forward), making it the more compelling value choice. Analysts rate Emerson Electric Co. (EMR) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — BWNB or EMR?
Over the past 5 years, Emerson Electric Co.
(EMR) delivered a total return of +59. 5%, compared to +29. 2% for Babcock & Wilcox Enterprises, I (BWNB). Over 10 years, the gap is even starker: EMR returned +206. 6% versus BWNB's +29. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — BWNB or EMR?
By beta (market sensitivity over 5 years), Babcock & Wilcox Enterprises, I (BWNB) is the lower-risk stock at 1.
16β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 31% more volatile than BWNB relative to the S&P 500.
04Which is growing faster — BWNB or EMR?
By revenue growth (latest reported year), Emerson Electric Co.
(EMR) is pulling ahead at 3. 0% versus -18. 1% for Babcock & Wilcox Enterprises, I (BWNB). On earnings-per-share growth, the picture is similar: Babcock & Wilcox Enterprises, I grew EPS 41. 5% year-over-year, compared to 17. 8% for Emerson Electric Co.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — BWNB or EMR?
Emerson Electric Co.
(EMR) is the more profitable company, earning 12. 7% net margin versus -6. 1% for Babcock & Wilcox Enterprises, I — meaning it keeps 12. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus 3. 9% for BWNB. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — BWNB or EMR?
All stocks in this comparison pay dividends.
Emerson Electric Co. (EMR) offers the highest yield at 1. 5%, versus 0. 6% for Babcock & Wilcox Enterprises, I (BWNB).
07Is BWNB or EMR better for a retirement portfolio?
For long-horizon retirement investors, Babcock & Wilcox Enterprises, I (BWNB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
16), 0. 6% yield). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BWNB: +29. 2%, EMR: +206. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between BWNB and EMR?
These companies operate in different sectors (BWNB (Technology) and EMR (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.